30 October 2026
Verici Dx plc
(“Verici Dx” or the “Company”)
Completion of Placing and Retail Offer to raise £8.75m
Directors’ Shareholdings
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, is pleased to confirm that following the passing of the Resolutions at the Shareholders’ General Meeting on Tuesday 27 October 2026, 2,691,999,983 new Ordinary Shares have been admitted to trading on AIM. The Company has raised total gross proceeds of £8.75m (net proceeds of £8.13m) through the Placing and WRAP Retail Offer.
As previously announced, Julian Baines and Sara Barrington, both directors of the Company, participated in the Placing. Following Admission of the Conditional Placing Shares their shareholdings are as set out below:
|
Previous Holding |
Share Placing Participation |
Shareholding following Admission |
|||
|
Shares |
% |
Shares |
Shares |
% |
|
|
Julian Baines |
8,548,482 |
0.37% |
10,000,000 |
18,548,482 |
0.28% |
|
Sara Barrington |
8,285,715 |
0.36% |
5,000,000 |
13,285,715 |
0.20% |
Capitalised terms used but not otherwise defined in this announcement have the meanings set out in the Circular published on 10 August 2026.
Enquiries:
|
Verici Dx plc |
||
|
Sara Barrington, CEO |
Via Walbrook PR |
|
|
Julian Baines, Chairman |
||
|
Singer Capital Markets (Nominated Adviser & Joint Broker) |
Tel: +44 (0)20 7496 3000 |
|
|
Russell Cook / Anastassiya Eley / Harry Littlewood |
||
|
Oberon Capital (Joint Broker) |
Tel: +44 (0)20 3179 0500 |
|
|
Mike Seabrook / Heena Karani |
||
|
Walbrook PR (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or [email protected] |
|
|
Alice Woodings / Rachel Broad |
Mob: +44 (0)7407 804 654 / +44 (0)7747 515 393 |
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Julian Baines |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Non-Executive Chairman |
|
b) |
Initial notification / Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Verici Dx plc |
|
b) |
LEI |
213800FI5WE4FVQ3G645 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.1 pence each ISIN: GB00BM8HZD43 |
|
b) |
Nature of the transaction |
Placing participation of new ordinary shares |
|
c) |
Price(s) and volume(s) |
Price: 0.2 pence Volume: 10,000,000 shares |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
28 October 2026 |
|
f) |
Place of the transaction |
Outside of trading venue - off market |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Sara Barrington |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Executive Officer |
|
b) |
Initial notification / Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Verici Dx plc |
|
b) |
LEI |
213800FI5WE4FVQ3G645 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.1 pence each ISIN: GB00BM8HZD43 |
|
b) |
Nature of the transaction |
Placing participation of new ordinary shares |
|
c) |
Price(s) and volume(s) |
Price: 0.2 pence Volume: 5,000,000 shares |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
28 October 2026 |
|
f) |
Place of the transaction |
Outside of trading venue - off market |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.